Sarepta Therapeutics | SRPT - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q3 Sep/2025 0.23 -0.13 Nov/04
FY2026Q2 Jun/2026 0.64 0.21 2.02 Aug/05
FY2026Q1 Mar/2026 3.16 1.11 -3.42 May/06
FY2025Q4 Dec/2025 -3.58 -1.27 1.90 Feb/25
FY2025Q3 Sep/2025 -0.13 -0.6 0.62 Nov/03




Eps Cambiamento Data
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
Agios Pharmaceuticals USD -1.69 0 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Amgen USD 6.29 1.14 2026-06
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Capricor Therapeutics USD -0.62 0.08 2025-12
Daiichi Sankyo JPY 37.72 11.03 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
Incyte USD 3.09 1.28 2026-06
Insmed USD -0.06 0.7 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Moderna USD -1.97 1.43 2026-06
Nektar Therapeutics USD -1.78 0.43 2026-03
Neurocrine Biosciences USD 2.85 0.91 2026-06
Novavax USD 0.13 0.59 2025-12
Pfizer USD 0.77 0.02 2026-06
PTC Therapeutics USD 0.92 0.95 2026-06
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Roche Holding CHF 10.98 2.61 2026-06
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 2.09 0.21 2026-06
Sarepta Therapeutics USD 0.64 2.52 2026-06
Tectonic Therapeutic USD -1.34 0.32 2026-03
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06